I agree that this site is using cookies. You can find further informations here.
X
Lisle, Thomas Landkildehus
30  results:
Search for persons X
?
1

Pre-existing TGF-β-specific T-cell immunity in patients wit..:

Mortensen, Rasmus Erik Johansson ; Holmström, Morten Orebo ; Lisle, Thomas Landkildehus...
Journal for ImmunoTherapy of Cancer.  11 (2023)  3 - p. e006432 , 2023
Link: https://doi.org/10.1136/..
 
?
2

An arginase1- and PD-L1-derived peptide-based vaccine for m..:

Grauslund, Jacob Handlos ; Holmström, Morten Orebo ; Martinenaite, Evelina...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Therapeutic cancer vaccination against mutant calreticulin ..:

Holmström, Morten Orebo ; Andersen, Morten ; Traynor, Sofie...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chron..:

Klausen, Uffe ; Grauslund, Jacob Handlos ; Jørgensen, Nicolai Grønne Dahlager...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
5

Arginase-2-specific cytotoxic T cells specifically recogniz..:

Weis-Banke, Stine Emilie ; Lisle, Thomas Landkildehus ; Perez-Penco, Maria...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005326 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Arginase-1 specific CD8+ T cells react toward malignant and..:

Glöckner, Hannah Jorinde ; Martinenaite, Evelina ; Landkildehus Lisle, Thomas...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
7

Therapeutic cancer vaccination against mutant calreticulin ..:

Holmström, Morten Orebo ; Andersen, Morten ; Traynor, Sofie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470021/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Pre-existing TGF-β-specific T-cell immunity in patients wit..:

Mortensen, Rasmus Erik Johansson ; Holmström, Morten Orebo ; Lisle, Thomas Landkildehus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040073/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

An arginase1- and PD-L1-derived peptide-based vaccine for m..:

Grauslund, Jacob Handlos ; Holmström, Morten Orebo ; Martinenaite, Evelina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996128/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Arginase-2-specific cytotoxic T cells specifically recogniz..:

Weis-Banke, Stine Emilie ; Lisle, Thomas Landkildehus ; Perez-Penco, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628693/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chron..:

Klausen, Uffe ; Grauslund, Jacob Handlos ; Jørgensen, Nicolai Grønne Dahlager...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723164/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

An arginase1- and PD-L1-derived peptide-based vaccine for m..:

Jacob Handlos Grauslund ; Morten Orebo Holmström ; Evelina Martinenaite...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1117466/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

Pre-existing TGF-β-specific T-cell immunity in patients wit..:

Mads Hald Andersen ; Özcan Met ; Inge Marie Svane...
https://jitc.bmj.com/content/11/3/e006432.full.  , 2023
Link: https://doi.org/10.1136/..
 
?
14

DataSheet_1_Therapeutic cancer vaccination against mutant c..:

Morten Orebo Holmström ; Morten Andersen ; Sofie Traynor...
doi:10.3389/fimmu.2023.1240678.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Therapeutic cancer vaccination against mutant calreticulin ..:

Morten Orebo Holmström ; Morten Andersen ; Sofie Traynor...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1240678/full.  , 2023
Link: https://doi.org/10.3389/..
 
1-15